Robert E. Gagnon

CIK 1504983 · Chief Financial Officer · last filed 2026-06-11

Robert E. Gagnon is a Chief Financial Officer who has filed 89 SEC Form 4 insider transactions across 6 companies since 2010. The most recent filing, for HBIO, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$4.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.14M

Companies

6

Total Filings

89

Lifetime Open-Market Net

-$4.11M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HBIO Chief Financial Officer 27,556 $6.08 $167.5K -$2.37M 26 2026-06-11
Opus Genetics, Inc. (OCUP) Delisted Chief Financial Officer 592,158 $1.17 $692.8K -$40.7K 3 2026-04-27
VSTM Director 41,678 $4.10 $170.9K -$338.4K 33 2025-12-18
BBLGW Director $15.34 $0 3 2025-06-06
CLEAN HARBORS INC (CLHB) Delisted EVP CFO and Treasurer 5,000 $0 1 2012-09-13
BIIB Vice President, Finance 3,999 $200.05 $800.0K -$1.37M 23 2012-03-01

Recent Filings

89 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-06-11 HBIO Grant (A) +16,556 $0 EDGAR
2026-04-27 Opus Genetics, Inc. (OCUP) Delisted Sell (S) −7,842 -$40.7K EDGAR
2026-01-26 Opus Genetics, Inc. (OCUP) Delisted Grant (A) +400,000 $0 EDGAR
2025-12-18 VSTM Sell (S) −283 -$2.6K EDGAR
2025-09-18 VSTM Sell (S) −281 -$2.8K EDGAR
2025-09-11 Opus Genetics, Inc. (OCUP) Delisted Grant (A) +200,000 $0 EDGAR
2025-07-18 HBIO Grant (A) +110,000 $0 EDGAR
2025-06-20 VSTM Sell (S) −284 -$1.6K EDGAR
2025-06-06 BBLGW Grant (A) $0 EDGAR
2025-05-27 VSTM Grant (A) +8,333 $0 EDGAR
Showing 110 of 89
Page 1 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.